CLAIM #2595 · AbbVie Inc (ABBV) · 2025Q1 earnings call · Apr 25, 2025 · due Dec 31, 2025
“But we still anticipate negative pricing headwinds on a full year basis.”
Scott Reents · CFO
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for ABBV ↗ · Claim quote is verbatim from the 2025Q1 earnings call.